ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,Y
3,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
11,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
13,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
13,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
15,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
19,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
20,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
21,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
21,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
21,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
22,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,3,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
22,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
23,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
23,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
24,1,Foreign body,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
24,2,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
